Partners, EMC collaborate on data and analytics platform

Laura Pedulli | | Health Exec | Economics

Partners HealthCare and EMC are collaborating to develop what they call The Partners Data Lake, a data and analytics platform to drive clinical research, improve care delivery and reduce costs. 

The Partners Data Lake seeks to accelerate clinically relevant research developed across the Partners HealthCare system into the clinical setting. Insights from the Partners Data Lake will be used to inform medical science, make research more efficient, improve diagnosis and treatment of disease and make healthcare more cost effective, according to a release.

The EMC federation of strategically aligned businesses is charged with developing products for the Partners Data Lake.

“Realizing the vision of big science that is delivered from our extensive research and clinical development efforts, from basic research to cancer genomics, requires new technology collaboration. The Partners Data Lake offers us the chance to lead the world in novel treatments and diagnostics,” said Shawn Murphy, MD, corporate director of research IS and computing at Partners, in a statement.

Laura Pedulli

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.